REVB vs. GOVX, EVOK, PHIO, BCEL, ENSC, PHAS, LGVN, ARTL, SNGX, and XCUR
Should you be buying Revelation Biosciences stock or one of its competitors? The main competitors of Revelation Biosciences include GeoVax Labs (GOVX), Evoke Pharma (EVOK), Phio Pharmaceuticals (PHIO), Atreca (BCEL), Ensysce Biosciences (ENSC), PhaseBio Pharmaceuticals (PHAS), Longeveron (LGVN), Artelo Biosciences (ARTL), Soligenix (SNGX), and Exicure (XCUR). These companies are all part of the "pharmaceutical preparations" industry.
GeoVax Labs (NASDAQ:GOVX) and Revelation Biosciences (NASDAQ:REVB) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, earnings, community ranking, media sentiment, profitability, analyst recommendations, risk, institutional ownership and dividends.
Revelation Biosciences has lower revenue, but higher earnings than GeoVax Labs. GeoVax Labs is trading at a lower price-to-earnings ratio than Revelation Biosciences, indicating that it is currently the more affordable of the two stocks.
GeoVax Labs' return on equity of -84.25% beat Revelation Biosciences' return on equity.
GeoVax Labs has a beta of 2.91, suggesting that its stock price is 191% more volatile than the S&P 500. Comparatively, Revelation Biosciences has a beta of 0.17, suggesting that its stock price is 83% less volatile than the S&P 500.
6.1% of GeoVax Labs shares are owned by institutional investors. Comparatively, 12.8% of Revelation Biosciences shares are owned by institutional investors. 5.7% of GeoVax Labs shares are owned by company insiders. Comparatively, 0.2% of Revelation Biosciences shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
GeoVax Labs presently has a consensus target price of $120.00, suggesting a potential upside of 7,353.42%. Given Revelation Biosciences' higher possible upside, research analysts clearly believe GeoVax Labs is more favorable than Revelation Biosciences.
Revelation Biosciences received 19 more outperform votes than GeoVax Labs when rated by MarketBeat users. However, 91.67% of users gave GeoVax Labs an outperform vote while only 63.83% of users gave Revelation Biosciences an outperform vote.
In the previous week, GeoVax Labs had 1 more articles in the media than Revelation Biosciences. MarketBeat recorded 1 mentions for GeoVax Labs and 0 mentions for Revelation Biosciences. Revelation Biosciences' average media sentiment score of 0.00 equaled GeoVax Labs'average media sentiment score.
Summary
GeoVax Labs and Revelation Biosciences tied by winning 7 of the 14 factors compared between the two stocks.
Get Revelation Biosciences News Delivered to You Automatically
Sign up to receive the latest news and ratings for REVB and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding REVB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Revelation Biosciences Competitors List
Related Companies and Tools
